Opinion

Video

Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials

Sarah Rockwell, PharmD, BCOP, provides an overview of the safety and efficacy data of bispecific antibodies investigated in the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 trials, providing critical insights into the results of each study.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
1 expert in this video
3 experts are featured in this series.
2 KOLs are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.